Recommendation of the President – Staloral 300 (mixture of allergen extracts)

On 1 August 2025, the President of the Agency for Health Technology Assessment and Tariff System issued recommendation No. 107/2025 on the reimbursement of the medicinal product Staloral 300 (mixture of allergen extracts) for the indication: treatment of children aged 5-11 years with moderate or severe allergic rhinitis caused by house dust, persistent despite the use of symptom-relieving medications, diagnosed on the basis of clinical history and a positive allergy test for house dust mites (skin prick tests or specific immunoglobulin E).

Publication in Public Information Bulletin (BIP) >>